Citations for
1CADASIL, NOTCH3
CADASIL mutations and shRNA silencing of NOTCH3 affect actin organization in cultured vascular smooth muscle cells.
Tikka S, Ng YP, Di Maio G, Mykkänen K, Siitonen M, Lepikhova T, Pöyhönen M, Viitanen M, Virtanen I, Kalimo H, Baumann M.
J Cereb Blood Flow Metab 32(12):2171-80. doi: 10.1038/jcbfm.2012.123. Epub 2012 Sep 5. 2012
2CADASIL, NOTCH3
Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysis.
Duering M, Karpinska A, Rosner S, Hopfner F, Zechmeister M, Peters N, Kremmer E, Haffner C, Giese A, Dichgans M, Opherk C.
Hum Mol Genet 20(16):3256-65. Epub 2011 May 30. 2011
3CADASIL, NOTCH3
Shorter telomeres in patients with cerebral autosomal dominant arteriopathy and leukoencephalopathy (CADASIL).
Ragno M, Pianese L, Pinelli M, Silvestri S, Cacchiò G, Di Marzio F, Scarcella M, Coretti F, Altamura F, Monticelli A, Castaldo I.
Neurogenetics 12(4):337-43. doi: 10.1007/s10048-011-0298-1. Epub 2011 Sep 1. 2011
4CADASIL, NOTCH3
Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation.
Takahashi K, Adachi K, Yoshizaki K, Kunimoto S, Kalaria RN, Watanabe A.
Hum Mol Genet 19(1):79-89. Epub .PMID: 19825845 2010
5CADASIL, NOTCH3
CADASIL mutations enhance spontaneous multimerization of NOTCH3.
Opherk C, Duering M, Peters N, Karpinska A, Rosner S, Schneider E, Bader B, Giese A, Dichgans M.
Hum Mol Genet 18(15):2761-7. Epub 2009 May 5. 2009
6CADASIL, NOTCH3
Autosomal dominant leukoencephalopathy with mild clinical symptoms due to cerebrovascular dysfunctions: a new disease entity?
Hirabayashi S, Wada T, Kondo Y, Arima K.
Brain Dev 30(2):146-50. Epub 2007 Jul 25.PMID: 17656057 2008
7CADASIL
Motor cortex cholinergic dysfunction in CADASIL: a transcranial magnetic demonstration.
Manganelli F, Ragno M, Cacchiò G, Iodice V, Trojano L, Silvaggio F, Scarcella M, Grazioli M, Santoro L, Perretti A.
Clin Neurophysiol 119(2):351-5. Epub 2007 Dec 11.PMID: 18065265 2008
8CADASIL, NOTCH3
A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient.
Pescini F, Bianchi S, Salvadori E, Poggesi A, Dotti MT, Federico A, Inzitari D, Pantoni L.
J Neurol Sci 267(1-2):170-3. Epub 2007 Nov 19.PMID: 18022198 2008
9CADASIL, NOTCH3
Sporadic vascular dementia as clinical presentation of a new missense mutation within exon 7 of NOTCH3 gene.
Pradotto L, Azan G, Doriguzzi C, Valentini C, Mauro A.
J Neurol Sci 271(1-2):207-10. Epub 2008 May 21. 2008
10CADASIL, HMID, NOTCH3
Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL.
Low WC, Junna M, Börjesson-Hanson A, Morris CM, Moss TH, Stevens DL, St Clair D, Mizuno T, Zhang WW, Mykkänen K, Wahlstrom J, Andersen O, Kalimo H, Viitanen M, Kalaria RN.
Brain 130(Pt 2):357-67. 2007
11CADASIL, NOTCH3
Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL.
Viswanathan A, Gschwendtner A, Guichard JP, Buffon F, Cumurciuc R, O'Sullivan M, Holtmannspötter M, Pachai C, Bousser MG, Dichgans M, Chabriat H.
Neurology 69(2):172-9. 2007
12NOTCH3, CADASIL
CADASIL mutations impair Notch3 glycosylation by Fringe.
Arboleda-Velasquez JF, Rampal R, Fung E, Darland DC, Liu M, Martinez MC, Donahue CP, Navarro-Gonzalez MF, Libby P, D'Amore PA, Aikawa M, Haltiwanger RS, Kosik KS.
Hum Mol Genet 14(12):1631-9. Epub 2005 Apr 27. 2005
13NOTCH3, CADASIL
Arg332Cys mutation of NOTCH3 gene in the first known Taiwanese family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Tang SC, Lee MJ, Jeng JS, Yip PK.
J Neurol Sci 228(2):125-8. Epub 2004 Dec 24. 2005
14CADASIL, NOTCH3, JAG1
Pathogenic Mutations Associated with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Differently Affect Jagged1 Binding and Notch3 Activity via the RBP/JK Signaling Pathway.
Joutel A, Monet M, Domenga V, Riant F, Tournier-Lasserve E.
Am J Hum Genet 74(2):338-47. Epub 2004 Jan 08. 2004
15CADASIL, NOTCH3
Distribution pattern of Notch3 mutations suggests a gain-of-function mechanism for CADASIL.
Donahue CP, Kosik KS.
Genomics 83(1):59-65. 2004
16NOTCH3, CADASIL
Detection of the founder effect in Finnish CADASIL families.
Mykkanen K, Savontaus ML, Juvonen V, Sistonen P, Tuisku S, Tuominen S, Penttinen M, Lundkvist J, Viitanen M, Kalimo H, Poyhonen M.
Eur J Hum Genet 12(10):813-9. 2004
17CADASIL, DLL1, Dll3, DLL4, JAG1, JAG2, NOTCH1, NOTCH2, NOTCH3, NOTCH4 , RBPJ, SCDO1
Notch signaling and inherited disease syndromes.
Gridley T.
Hum Mol Genet 12 Spec No 1:R9-13. Review. 2003
18CADASIL, NOTCH3
Genetic, clinical and pathological studies of CADASIL in Japan: a partial contribution of Notch3 mutations and implications of smooth muscle cell degeneration for the pathogenesis.
Santa Y, Uyama E, Chui de H, Arima M, Kotorii S, Takahashi K, Tabira T.
J Neurol Sci 212(1-2):79-84. 2003
19CADASIL, NOTCH3
A novel mitochondrial DNA mutation and a mutation in the Notch3 gene in a patient with myopathy and CADASIL.
Finnila S, Tuisku S, Herva R, Majamaa K.
J Mol Med 79(11):641-7. 2001
20CADASIL, NOTCH3
Diagnostic Notch3 sequence analysis in CADASIL: three new mutations in Dutch patients. Dutch CADASIL Research Group.
Oberstein SA, et al.
Neurology 52(9):1913-5. 1999
21CADASIL, NOTCH3
Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients.
Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssiere C, Cruaud C, Maciazek J, Weissenbach J, Bousser MG, Bach JF, Tournier-Lasserve E.
Lancet 350(9090):1511-5. 1997
22CADASIL
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, genetic homogeneity, and mapping of the locus within a 2-cM interval.
Ducros A, et al.
Am J Hum Genet 58 : 171-181. 1996
23CADASIL
Identification of a key recombinant narrows the CADASIL gene region to 8cM and argues against allelism of CADASIL and familial hemiplegic migraine.
Dichgans M, et al.
Genomics 32 : 151-154. 1996
24CADASIL, NOTCH3
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.
Joutel A, et al.
Nature 383 : 707-710. 1996
25CADASIL
An additional monogenic disorder that masquerades as multiple sclerosis.
Vahedi K, et al.
Am J Med Genet 65 : 357-358. 1996
26CADASIL, MAWMA
Autosomal dominant migraine with MRI white-matter abnormalities mapping to the CADASIL locus.
Chabriat H, et al.
Neurology 45 : 1086-1091. 1995
27CADASIL
Clinical spectrum of CADASIL : a study of 7 families.
Chabriat H, et al.
Lancet 346 : 934-939. 1995
28CADASIL, MHP1
Familial hemiplegic migraine and autosomal dominant arteriopathy with leukoencephalopathy (CADASIL).
Hutchinson M, et al.
Ann Neurol 38 : 817-824. 1995
29CADASIL
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy : a clinicopathological and genetic study of a Swiss family.
Jung HH, et al.
J Neurol Neurosurg Psychiatry 59 : 138-143. 1995
30CADASIL
New phenotype of the cerebral autosomal dominant arteriopathy mapped to chromosome 19 : migraine as the prominent clinical feature.
VŽrin M, et al.
J Neurol Neurosurg Psychiatry 59 : 579-585. 1995
31CADASIL
Hereditary multi-infarct dementia unlinked to chromosome 19q12 in a large Scottish pedigree : evidence of probable locus heterogeneity.
St Clair D, et al.
J Med Genet 32 : 57-60. 1995
32CADASIL
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). Clinical, neuroimaging, pathological and genetic study of a large Italian family.
Sabbadini G, et al.
Brain 118 : 207-215. 1995
33CADASIL, MHP1
Familial migraine : exclusion of the susceptibility gene from the reported locus of familial hemiplegic migraine on 19p.
Hovatta I, et al.
Genomics 23 : 707-709. 1994
34CADASIL
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12.
Tournier-Lasserve E, et al.
Nat Genet 3 : 256-259. 1993